Accellacare of McFarland

Ames, Iowa 50010

2 studies enrolling now · 4 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, HER2-positive Breast Cancer, Obese, Obesity

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer — Recruiting now
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus — Running, not enrolling